中国首个诱导多能干细胞（iPSC）衍生细胞疗法治疗帕金森病取得突破性进展。记者今天从上海市东方医院获悉，该院与士泽生物医药（苏州）有限 ...

For many groups that use iPSCs, weekend lab visits—and expensive culture media—are considered inescapable facts of research. In an effort to solve both problems, researchers at Northwestern University ...

上海团队牵头完成了我国首例临床级iPSC衍生细胞移植治疗帕金森病。新民晚报记者今日了解到，经过一年的随访，患者运动能力及生活质量较细胞 ...

It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response in patients, however, there has recently been an increased demand for type O female blood-derived iPSCs.

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that ...